TipRanks
Perspective Therapeutics (DE:AAJ0)
FRANKFURT:AAJ0
Germany Market

Perspective Therapeutics (AAJ0) Technical Analysis

0 Followers

Summary of all the Indicators

Overall Consensus
Sell
5Bullish
3Neutral
14Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Perspective Therapeutics’s (AAJ0) Moving Averages Convergence Divergence (MACD) indicator is -0.10, suggesting Perspective Therapeutics is a Buy.
Perspective Therapeutics’s (AAJ0) 20-Day exponential moving average is 2.18, while Perspective Therapeutics’s (AAJ0) share price is €2.67, making it a Sell.
Perspective Therapeutics’s (AAJ0) 50-Day exponential moving average is 2.36, while Perspective Therapeutics’s (AAJ0) share price is €2.67, making it a Sell.

Perspective Therapeutics (AAJ0) Pivot Points

Oct 19, 2026, 11:37 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.84
1.87
1.92
1.95
2.01
2.03
2.09
Fibonacci
1.87
1.90
1.92
1.95
1.98
2.00
2.03
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Perspective Therapeutics (AAJ0) Moving Averages

Oct 19, 2026, 11:37 AM
Period
Simple
Exponential
MA5
2.08Sell
2.05Sell
MA10
2.12Sell
2.10Sell
MA20
2.17Sell
2.18Sell
MA50
2.42Sell
2.36Sell
MA100
2.54Sell
2.54Sell
MA200
3.03Sell
2.71Sell
Perspective Therapeutics’s (AAJ0) 10-Day exponential moving average is 2.10, while Perspective Therapeutics’s (AAJ0) share price is €2.67, making it a Sell.
Perspective Therapeutics’s (AAJ0) 100-Day exponential moving average is 2.54, while Perspective Therapeutics’s (AAJ0) share price is €2.67, making it a Sell.
Perspective Therapeutics’s (AAJ0) stock price is €2.67 and Perspective Therapeutics’s (AAJ0) 50-day simple moving average is 2.42, creating a Sell signal.
Perspective Therapeutics’s (AAJ0) stock price is €2.67 and Perspective Therapeutics’s (AAJ0) 100-day simple moving average is 2.54, creating a Sell signal.
Perspective Therapeutics’s (AAJ0) stock price is €2.67 and Perspective Therapeutics’s (AAJ0) 200-day simple moving average is 3.03, creating a Sell signal.

Perspective Therapeutics (AAJ0) Technical Indicators

Oct 19, 2026, 11:37 AM
Name
Value
Implied Action
RSI (14)
40.39
Neutral
STOCH (9,6)
13.64
Buy
STOCHRSI (14)
12.83
Buy
MACD (12,26)
-0.10
Buy
ADX (14)
17.40
Buy
Williams %R
-78.92
Buy
CCI (14)
-99.49
Neutral
ATR (14)
0.11
-
Ultimate Oscillator
45.76
Neutral
ROC
-5.27
Sell
Perspective Therapeutics’s (AAJ0) Relative Strength Index (RSI) is 40.39, creating a Neutral signal.
Perspective Therapeutics’s (AAJ0) Trend Strength Indicator (ADX) is 17.40, creating a Buy signal.
Perspective Therapeutics’s (AAJ0) Commodity Channel Index (CCI) is -99.49, creating a Neutral signal.
Perspective Therapeutics’s (AAJ0) Price Rate of Change (ROC) is -5.27, creating a Sell signal.

FAQ

Is AAJ0 a Buy, Hold, or Sell?
Based on AAJ0’s technical indicators, AAJ0 is a Sell.
    What is AAJ0’s RSI (14)?
    AAJ0’s RSI (14) is 40.39, which suggests AAJ0 is a Neutral.
      What is AAJ0’s MACD?
      AAJ0’s MACD is -0.10, which suggests AAJ0 is a Buy.
        What is AAJ0’s 5-day moving average?
        AAJ0’s 5-day moving average is 2.08, which suggests AAJ0 is a Sell.
          What is AAJ0’s 20-day moving average?
          AAJ0 20-day moving average is 2.17, which suggests AAJ0 is a Sell.
            What is AAJ0’s 50-day moving average?
            AAJ0’s 50-day moving average is 2.42, which suggests AAJ0 is a Sell.
              What is AAJ0’s 200-day moving average?
              AAJ0’s 200-day moving average is 3.03, which suggests AAJ0 is a Sell.
                What is AAJ0’s Williams % R (14)?
                AAJ0’s Williams % R (14) is -78.92, which suggests AAJ0 is a Buy.
                  What is AAJ0’s CCI (14)?
                  AAJ0’s CCI (14) is -99.49, which suggests AAJ0 is a Neutral.
                    What is the share price of Perspective Therapeutics?